devinitorg/iati-policy-markers huggingface dataset:
NIHR Global Health Research Group on Disrupting the cycle of GEndered violence & Poor Mental health among Migrants in precarious Situations (GEMMS) The mental health and psychosocial (MH) consequences of precarity experienced by migrants is widely acknowledged as a global health challenge. Migrants inhabiting and moving across ‘precarious situations’ are at high risk of Gendered Violence (GV), at both the interpersonal and structural level. Combined with the inability to report or access healthcare and other systems of protection, and invisibility in policy and planning results in excess burden and entrapment in a damaging cycle of GV
and MH. In order to inform the design of appropriate interventions that address these burdens, it is necessary to improve our understanding of the relationship between drivers of risk among migrants in precarious situations. Responding to conceptual, empirical and intervention gaps affecting this global public health crisis, we build on existing interdisciplinary expertise and prior collaborations to establish a Global Health Research Group on GEndered violence & Poor Mental health among Migrants in
precarious Situations’ (GEMMS). GEMMS brings together clinical, psychosocial, sociological and public health expertise within the University of Essex with expertise from South Asia and Southern Africa to advance this agenda.

Aims:
Working in four precarious situations with diverse migrant groups in India, Myanmar, South Africa and Zimbabwe, we aim to create the necessary conceptual and methodological tools and actions that may create solutions to disrupt the damaging cycle of GV and poor MH and improve migrants' wellbeing WP1: Situational Assessment And Data Appraisal – evaluate existing evidence and service gaps to inform the design of research and intervention tools and conceptual framework to advance other WPs.
WP2: Lived Experiences – conduct research with migrants, health providers using mixed methods integrated with Participatory Action Research to generate new knowledge about:
• burden and lived experiences of the intersecting risks of GV and poor MH
• socio-economic determinants and contextual mechanisms
• distribution and accessibility of resources that support resilience and well-being.
WP3: Actions & Interventions - Drawing on WP1 &2, develop a participatory approach to co-design actions and a training and support intervention for healthcare workers and service providers
NIHR Global Health Research Centres: Call 1 The Global Health Research Centres programme funds research-driven partnerships between institutions in low and middle income countries (LMICs) and in the UK. 
The Centres undertake high quality research and strengthen LMIC institutional capacity to undertake, manage and disseminate high-quality applied health research. 
The Global Health Research Centres programme funds high quality applied health research in LMICs and supports the development of a critical mass of sustainable, competitive research capacity. 
By delivering high quality research evidence and strengthening research capacity at all levels, our Global Health Research Centres will improve health outcomes for people in LMICs and support sustainable growth of the LMIC research ecosystem. The Global Health Research Centres programme funds ambitious, transformative, innovative and collaborative consortia of research institutions in the UK and in LMICs that are eligible for Official Development Assistance (ODA). High quality research and research capacity strengthening in LMICs are equally essential components of the programme. 

Each funding call addresses an area where there is a need for coordinated, high quality research in LMICs to increase the global evidence base. The first funding call will fund and designate NIHR Global Health Research Centres in non-communicable diseases.
Centres also have a focus on capacity building and training in partner LMIC institutions, through:
-strengthening career pathways for researchers, from masters students to senior academics
-developing and retaining a trained and networked global cohort of experts and future research leaders
-supporting the training and development of research managers and other non-academic staff.
NIHR RIGHT2: Transforming Access to Care for Serious Mental Disorders in Slums A UK and low- and middle-income country (LMIC) research partnership to increase access to care and improve outcomes of serious mental disorders (SMDs) in slums in India and Nigeria, through development of an innovative collaborative care model involving traditional/faith healers, mental health professionals, primary care practitioners and community health workers (CHWs). Slum populations in low- and middle-income countries (LMICs) have high rates of serious and enduring mental disorders (SMDs) and very poor access to professional medical mental health care. Sufferers and their families often choose traditional and faith-based practices since these are more accessible, considered affordable, and are in tune with their cultural beliefs and traditions. Faith-based and traditional healing can play an important part in delivering care in LMICs, but those with SMDs require additional biomedical treatment and follow-up. This projects’ primary objective is to improve access to care and improve the outcomes for people with SMDs, through fostering cooperation between traditional/faith-based healers and professional medical services. The work focuses on two specifically identified slum populations, in New Dehli (India) and in Ibadan (Nigeria).
The researchers will:
1. investigate each communities’ awareness and understanding of SMDs, including working with CHWs and traditional/faith-based healers to understand who seeks and receives care from these healers and how those processes could be linked to medical care.  
2. Develop training packages to support CHWs and traditional/faith-based healers to identify SMDs that require referral to medical care, and create a mechanism for referral to medical care and other support services. 
3. Develop street theatre performances and documentaries to reach and engage the relevant communities to raise awareness and reduce stigma, and share information on how to access care for SMDs. 
4. The overall output from the work is an innovative collaborative care model involving traditional/faith healers, mental health professionals, primary care practitioners and CHWs in Nigeria and India.
Royal Society of Tropical Medicine and Hygiene Small Grants Scheme 2020 A partnership with the Royal Society of Tropical Medicine and Hygiene (RSTMH) to support small grant awards for early career researchers based in low- and middle-income countries (LMICs). Awards will specifically support research and capacity development for LMIC researchers which will benefit patients and the public in LMICs Enable early career researchers and global health professionals in low- and middle-income countries to undertake clinical and applied health research or fieldwork, and access training in grant writing and mentoring; 'pump-prime' funding to early career researchers in strategic research areas; increase the quality and number of applications to other NIHR Global Health Research funded schemes
Good Financial Grants Practice The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided this funding through the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). The Good Financial Grant Practice (GFGP) is a programme established to strengthen Africa’s research and development infrastructure by developing an innovative standard for the best practices in the management of funds awarded to grantees. The NIHR's funding supported the phase II development of the GFGP standard and associated assessment tools, creating a new and integrated system for the financial governance of grant funds , including international aid, awarded to grantees which will standardise, simplify and strengthen the governance of grant funding. 1) The development of a web-based assessment system to enable pre-award and compliance assessments of grantees to the Good Financial Grant Practice (GFGP) standard. 2) The recruitment of a secretariat at the African Academy of Sciences (AAS) to manage and support the system.
NIHR RIGHT1: Improving experiences of severe stigmatising skin diseases in Ghana and Ethiopia A UK and low- and middle-income country (LMIC) research partnership that aims to improve outcomes for individuals with leprosy, yaws, Buruli ulcer and cutaneous leishmaniasis. The Skin Health Africa Research Programme (SHARP) is a an interdiscplinary partnership of clinicians, social scientists, epidemiologists, statisticians and laboratory scientists working with communities affected by severe stigmatising skin diseases. To improve outcomes for people with severe stigmatising skin diseases by strengthening the care cascade through scalable strategies for earlier detection, improving management to reduce disability and counteracting stigma:
1. to evaluate integrated community-based strategies for early diagnosis, adherence support and stigma reduction
2. to undertake facility-based trials of dressings for Buruli ulcer
3. to develop clinical and patient reported outcome measures for cutaneous leishmaniasis
4. to promote collaboration and build research capacity in Ghana and Ethiopia.
Global Effort on COVID-19 (GECO) Health Research The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The Global Effort on COVID-19 (GECO) Health Research is a cross UK government funding call aiming to support applied health research that will address COVID-19 knowledge gaps in ODA-eligible countries. The focus is on understanding the pandemic and mitigating its health impacts in low and middle-income country (LMIC) contexts. The call prioritises epidemiology, clinical management, infection control and health system responses, in alignment with the World Health Organization (WHO) COVID-19 Global Research Roadmap.
Proposal and Partnership Development Awards (PPDA) for NIHR Research and Innovation for Global Health Transformation (RIGHT) call 1 Stage 2 applicants The purpose of Proposal and Partnership Development Awards (PPDA) funding is to improve the quality and likelihood of success of the projects funded through the NIHR Research and Innovation for Global Health Transformation (RIGHT) programme. Applicants that are successful at RIGHT Stage 1 and invited to submit a Stage 2 application are eligible for a PPDA, subject to satisfactory submission of a PPDA application. Not all Stage 2 applicants awarded a PPDA go on to secure RIGHT programme funding. For RIGHT Call 1, PPDA were extended to 13 applicant organisations to support partnership development and the preparation of a RIGHT Stage 2 application. Proposal and Partnership Development Awards (PPDA) provide funding of up to £10,000 for organisations applying to NIHR Research and Innovation for Global Health Transformation (RIGHT) programme funding to:
1.	Support applicants to work collaboratively with all study partners to develop the stage 2 application
2.	Enhance partnerships across the proposed research collaboration
3.	Initiate preparation of study governance documentation (i.e. due diligence and finance assurance policies)
PPDA funds must be spent between the notification of RIGHT stage 1 outcome and the submission of the RIGHT stage 2 application.
NIHR Research and Innovation for Global Health Transformation: Call 1 National Institute for Health and Care Research (NIHR)’s first Research and Innovation for Global Health Transformation (RIGHT) call. RIGHT funds cutting-edge interdisciplinary applied health research in key areas in in low- and middle-income countries (LMICs) where a strategic and targeted investment can result in a transformative impact.
RIGHT Call 1 addresses research in three key areas: epilepsy, infection-related cancers and severe stigmatising skin diseases. UK universities and research institutes were invited to submit applications including a co-applicant or joint lead applicant from an LMIC relevant to the research proposal. Research must be focused on improving the health and welfare of people in LMICs. 1. Deliver research for the primary benefit to the health and welfare of the poorest individuals living in LMICs, typically through research for the prevention of ill health and optimal disease management, in three research areas: (1) Epilepsy (2) Infection-related cancers (3) Severe stigmatising skin diseases. 
2. Strengthen capacity for research and knowledge exchange through equitable partnerships between researchers in the UK and LMICs. 
3. Promote interdisciplinary approaches to working (including, but not limited to: clinical, health economics, statistics, qualitative and social sciences), to ensure that research objectives can be delivered.
Sponsorship for the 11th European Congress on Tropical Medicine and International Health NIHR provided sponsorship to the Royal Society of Tropical Medicine and Hygiene to support two panel members from low and middle income countries to attend the 11th European Congress on Tropical Medicine and International Health To support a joint panel session on multimorbidity, including providing travel sponsorships for low and middle income country attendees to participate in the conference
NIHR Global Health Research Group on Respiratory Rehabilitation (Global RECHARGE) A UK and low- and middle-income country (LMIC) partnership that aims to deliver an intervention to reduce disability through pulmonary rehabilitation in Kyrgyzstan, Uganda, India and Sri Lanka. 1) Understand the challenges of providing a pulmonary rehabilitation (PR) in LMIC countries. 2) Establish culturally appropriate and innovative methods of delivering PR in LMIC partner sites and evaluate the new PR programmes.  3) Understand the workforce and training issues in the LMIC partners to support the delivery of clinically effective PR programmes. 4) Set priorities and outcome measures for the delivery and evaluation of a co-produced PR programme. 5) Develop an international standardised database (with anonymised individual patient data) to allow international benchmarking of PR programmes and to strengthen infrastructure for future research in this area. 6) Develop multi-disciplinary research capacity, strong governance and data management.
NIHR GRP: Mobile health (mHealth) supported self-care among tertiary education students in Zimbabwe (MASCOT) To work together with students to develop a self-care strategy that combines mHealth and decision aids and enables students to optimally use HIV and contraception services. The study is divided into five stages and builds on another study where a self-care strategy supported by an mHealth tool (without decision aids) was developed. In the first stage, we will conduct research to find out what students prefer a self-care strategy that is combined with decision aids to look like. In the second stage, we will use findings from the first stage to develop blueprints for two decision aids: one for contraception and the other for HIV prevention. In the next stage we will integrate the decision aids with the existing mHealth tool through a group activity that includes students and experts in health and mHealth. In the fourth stage we will test whether the whole self-care strategy, supported by the mHealth tool with decision aids, works well. Finally, in the fifth stage we will compare colleges/universities that use the self-care strategy with those that do not, to see whether promoting self-care results in more students taking up HIV and contraception services. We will also make recommendations on how the strategy can be provided outside colleges/universities. This project has 6 specific objectives:

1. Explore preferences for decision aids and how they can be incorporated into the existing self-care intervention. 

2. Develop/adapt blueprints for human immunodeficiency virus (HIV) prevention and contraception decision aids according to student values/preferences. 

3. Integrate the existing mHealth tool with decision aids for HIV prevention and contraception.

4. Determine feasibility and acceptability of MASCOT (mobile health (mHealth) supported self-care among tertiary education students in Zimbabwe) in two colleges/universities. 

5. Determine the effectiveness of MASCOT in improving uptake of HIV and contraception services and its societal costs in a cluster randomised trial in 16 colleges/universities. 

6. Explore how to adapt MASCOT for other settings.
NIHR Global Health Research Group on Road Safety A UK and low- and middle-income country (LMIC) partnership that aims to reduce the number and severity of road accidents in LMICs through the underpinning philosophy of local solutions for local problems. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Capture the current situation in each LMIC through local data collection of the road transport system. 2) Develop solutions and countermeasures from a socio-technical systems-based perspective based on the local data. 3) Evaluate these solutions in simulated environments (a significant output of the project is establishing simulator facilities at each LMIC institution). 4) Disseminate findings at local and national levels in order to shape the interventions, policy and regulations to reduce road crashes and associated public health trauma.
Global Alliance for Chronic Diseases prevention and management of mental disorders call The National Institute for Health and Care Research (NIHR), in partnership with the UK Medical Research Council (MRC) and the Global Alliance for Chronic Diseases (GACD), funds implementation research to generate new knowledge on interventions and their implementation for the prevention or management of chronic non-communicable diseases (NCDs). The GACD funding call on Prevention and Management of Mental Health Conditions focuses on implementation research on child, adolescent and adult age onset mental disorders in low- and middle-income countries, including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders in low- and middle-income countries. This activity is a component of the Global Alliance for Chronic Diseases programme, GB-GOV-10-GACD. Advance prevention strategies and implementation of mental health interventions, alleviating global burden of mental disorders;  Establish the contextual effectiveness of mental health intervention(s), including at health systems level; Improve tailored prevention and treatment; develop affordable management and treatment modalities for mental disorders and expand access to care; Inform health service providers, policy and decision makers on effective scaling up of mental health interventions at local, national and regional levels, including affordability aspects for users and health providers; Reduce health inequalities and inequities, including due consideration of gender and age issues where relevant, in the prevention, treatment and care of mental disorders at both local and global levels; Maximise the use of existing relevant programmes and platforms (e.g. research, data, and delivery platforms); Contribute to the United Nations' Sustainable Development Goals 3, 5, 10 and 17, the Global Action Against Dementia and the First World Health Organization (WHO) Ministerial Conference on Dementia, the WHO Mental Health Action Plan 2013-2020.
Royal Society of Tropical Medicine and Hygiene Small Grants Scheme 2021 A partnership with the Royal Society of Tropical Medicine and Hygiene (RSTMH) to support small grant awards for early career researchers based in low- and middle-income countries (LMICs). Awards will specifically support research and capacity development for LMIC researchers which will benefit patients and the public in LMICs The 2021 small grants scheme will: 
1) 	enable early career researchers and global health professionals in LMICs to undertake clinical and applied health research or fieldwork
2) 	develop research and management skills of early career LMIC researchers through leading a small independent research project
3) 	establish a peer cohort of awardees to increase collaboration and networking opportunities
4) 	enhance future funding opportunities of LMIC early career researchers
5) 	strengthen a beneficial scheme to ensure that a higher proportion of fundable applications receive funding than previous years
Support to NIHR Coordinating Centres for global health research resourcing Support provided for resourcing at NIHR Coordinating Centres to enable them to carry out global health research activities. To support NIHR Coordinating Centres to effectively deliver NIHR Global Health Research programmes.
Joint Global Health Trials Initiative The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. The aim of this programme is to generate new knowledge to contribute to improving health in low and middle income countries (LMICs). Priority will be given to proposals most likely to yield implementable results and designed to address the major causes of mortality or morbidity in LMICs. To fund rigorous research to produce implementable evidence addressing questions of major importance to mortality and morbidity in low- and middle-income countries.
NIHR RIGHT1:Evaluation and Transfer of Precise Diagnosis for Improved Outcomes of Children and Young Adults with Epstein Barr Virus-driven Lymphoma A UK and low- and middle-income country (LMIC) research partnership that aims to test two new diagnostic technologies that can help provide fast and reliable diagnosis for Epstein-Barr virus (EBV) in sub-Saharan Africa. 1. To test two new technologies which, by leapfrogging conventional diagnostic approaches, could bring fast and precise diagnosis of Epstein Barr Virus Lymphoma to sub-Sahara Africa; 
2. To generate viral and tumour sequence information to inform the design of future screening programmes and vaccine development; 
3. To perform a clinical validation of our diagnostic tools and then a controlled before-after study to test whether these speed up diagnosis, increase the number of children diagnosed and treated, and ultimately improve survival compared to gold-standard pathology.